• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-淀粉样蛋白抗体治疗可使斑块诱导的神经突改变迅速恢复正常。

Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations.

作者信息

Lombardo Julianne A, Stern Edward A, McLellan Megan E, Kajdasz Stephen T, Hickey Gregory A, Bacskai Brian J, Hyman Bradley T

机构信息

Center for Aging, Genetics, and Neurodegeneration, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.

出版信息

J Neurosci. 2003 Nov 26;23(34):10879-83. doi: 10.1523/JNEUROSCI.23-34-10879.2003.

DOI:10.1523/JNEUROSCI.23-34-10879.2003
PMID:14645482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6740984/
Abstract

The accumulation of amyloid-beta into insoluble plaques is a characteristic feature of Alzheimer's disease. Neuronal morphology is distorted by plaques: rather than being essentially straight, they are substantially more curved than those in control tissue, their trajectories become altered, and they are frequently distended or swollen, presumably affecting synaptic transmission. Clearance of plaques by administration of antibodies to amyloid-beta is a promising therapeutic approach to the treatment of Alzheimer's disease, leading to stabilization of dementia by an unknown cellular mechanism. The effect of plaque clearance on plaque-induced neuronal alterations has not been studied previously. Here we show that both plaques and neuritic lesions are reversible in a strikingly short period of time after administration of a single dose of amyloid-beta antibody. Amyloid clearance and recovery of normal neuronal geometries were observed as early as 4 d and lasted at least 32 d after a single treatment. These results demonstrate that, once plaques are cleared, neuronal morphology is self-correcting and that passive antibody treatment has the potential to reverse neuronal damage caused by Alzheimer's disease and, hence, directly impact cognitive decline. Moreover, the rapid normalization of neuritic dystrophy suggests an unexpected degree of plasticity in the adult nervous system.

摘要

淀粉样β蛋白聚积形成不溶性斑块是阿尔茨海默病的一个特征性表现。斑块会使神经元形态发生扭曲:与正常组织中的神经元相比,它们不再基本呈直线状,而是弯曲程度显著增加,其轨迹发生改变,并且经常出现扩张或肿胀,这可能会影响突触传递。通过给予抗淀粉样β蛋白抗体来清除斑块是一种很有前景的治疗阿尔茨海默病的方法,它通过一种未知的细胞机制使痴呆症状得到稳定。此前尚未研究过斑块清除对斑块诱导的神经元改变的影响。在此我们表明,在单次给予淀粉样β蛋白抗体后,斑块和神经炎性病变在极短的时间内都是可逆的。单次治疗后,最早在4天时就观察到淀粉样蛋白清除以及神经元恢复正常形态,并且至少持续32天。这些结果表明,一旦斑块被清除,神经元形态会自我纠正,被动抗体治疗有可能逆转由阿尔茨海默病导致的神经元损伤,从而直接影响认知衰退。此外,神经炎性营养不良的快速恢复表明成年神经系统具有出人意料的可塑性程度。

相似文献

1
Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations.β-淀粉样蛋白抗体治疗可使斑块诱导的神经突改变迅速恢复正常。
J Neurosci. 2003 Nov 26;23(34):10879-83. doi: 10.1523/JNEUROSCI.23-34-10879.2003.
2
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.人抗淀粉样蛋白-β主动免疫对神经突形态和 Tau 病理学的有益作用。
Brain. 2010 May;133(Pt 5):1312-27. doi: 10.1093/brain/awq056. Epub 2010 Mar 31.
3
The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.阿尔茨海默病中β-淀粉样蛋白斑块的形态学表型及相关神经突改变。
Neuroscience. 2001;105(1):99-107. doi: 10.1016/s0306-4522(01)00169-5.
4
Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.转基因阿尔茨海默病小鼠中硫黄素-S阳性淀粉样斑块的形态学特征及被动β-淀粉样蛋白免疫治疗对其清除的影响。
Am J Pathol. 2004 Sep;165(3):987-95. doi: 10.1016/s0002-9440(10)63360-3.
5
Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice.抗淀粉样蛋白β抗体治疗可促进PDAPP转基因小鼠中与淀粉样蛋白相关的神经突营养不良的快速恢复。
J Clin Invest. 2005 Feb;115(2):428-33. doi: 10.1172/JCI23269.
6
Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.通过相衬X射线计算机断层扫描对阿尔茨海默病小鼠模型中的淀粉样斑块进行定量分析。
Neuroscience. 2006;138(4):1205-13. doi: 10.1016/j.neuroscience.2005.12.036. Epub 2006 Feb 7.
7
Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.颅内注射抗β-淀粉样蛋白抗体通过与小胶质细胞激活无关和相关的机制减少β-淀粉样蛋白沉积。
J Neurosci. 2003 May 1;23(9):3745-51. doi: 10.1523/JNEUROSCI.23-09-03745.2003.
8
Limited clearance of pre-existing amyloid plaques after intracerebral injection of Abeta antibodies in two mouse models of Alzheimer disease.在两种阿尔茨海默病小鼠模型中,脑内注射β-淀粉样蛋白抗体后,已存在的淀粉样斑块清除有限。
J Neuropathol Exp Neurol. 2008 Jan;67(1):30-40. doi: 10.1097/nen.0b013e31815f38d2.
9
Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.阿尔茨海默病中神经炎性斑块结构组织的重新评估。
J Neuropathol Exp Neurol. 1993 Nov;52(6):619-32. doi: 10.1097/00005072-199311000-00009.
10
A single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer's disease mouse model.单次被动免疫疗法对阿尔茨海默病小鼠模型的突触和神经突具有持久益处。
Brain Res. 2009 Jul 14;1280:178-85. doi: 10.1016/j.brainres.2009.05.045. Epub 2009 May 22.

引用本文的文献

1
Mouse models of Anti-Aβ immunotherapies.抗淀粉样前体蛋白(Aβ)免疫疗法的小鼠模型。
Mol Neurodegener. 2025 May 13;20(1):57. doi: 10.1186/s13024-025-00836-x.
2
Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier.双特异性治疗性抗体通过血脑屏障的受体介导药物递送
Front Drug Deliv. 2023;3. doi: 10.3389/fddev.2023.1227816. Epub 2023 Jul 10.
3
Neuroprotective Effects of a Multi-Herbal Extract on Axonal and Synaptic Disruption and Cognitive Impairment .一种多草药提取物对轴突和突触破坏及认知障碍的神经保护作用
J Alzheimers Dis Rep. 2023 Jan 27;7(1):51-76. doi: 10.3233/ADR-220056. eCollection 2023.
4
All the Tau We Cannot See.所有我们看不见的tau蛋白
Annu Rev Med. 2023 Jan 27;74:503-514. doi: 10.1146/annurev-med-042921-023749. Epub 2022 Nov 15.
5
Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer's Disease.对阿尔茨海默病生理病理学、诊断及治疗方法的当前认识
Biomedicines. 2021 Dec 14;9(12):1910. doi: 10.3390/biomedicines9121910.
6
Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.治疗性抗体——天然和病理性障碍及其克服策略。
Pharmacol Ther. 2022 May;233:108022. doi: 10.1016/j.pharmthera.2021.108022. Epub 2021 Oct 20.
7
Axonal Degeneration in AD: The Contribution of Aβ and Tau.阿尔茨海默病中的轴突退化:β-淀粉样蛋白和 Tau 蛋白的作用。
Front Aging Neurosci. 2020 Oct 15;12:581767. doi: 10.3389/fnagi.2020.581767. eCollection 2020.
8
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model.抗人 TREM2 诱导小胶质细胞增殖并减少阿尔茨海默病模型中的病理。
J Exp Med. 2020 Sep 7;217(9). doi: 10.1084/jem.20200785.
9
Innate immunity in Alzheimer's disease: the relevance of animal models?阿尔茨海默病中的固有免疫:动物模型的相关性?
J Neural Transm (Vienna). 2018 May;125(5):827-846. doi: 10.1007/s00702-017-1729-4. Epub 2017 May 17.
10
Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset.普通狨猴中tau蛋白过度磷酸化和营养不良性小胶质细胞的证据。
Front Aging Neurosci. 2016 Dec 22;8:315. doi: 10.3389/fnagi.2016.00315. eCollection 2016.

本文引用的文献

1
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.抗β-淀粉样蛋白抗体可减缓阿尔茨海默病的认知衰退。
Neuron. 2003 May 22;38(4):547-54. doi: 10.1016/s0896-6273(03)00294-0.
2
Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.用β-淀粉样肽免疫后人类阿尔茨海默病的神经病理学:一例报告
Nat Med. 2003 Apr;9(4):448-52. doi: 10.1038/nm840. Epub 2003 Mar 17.
3
In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories.阿尔茨海默病转基因小鼠模型的体内多光子成像显示,神经突轨迹中存在明显的硫黄素-S相关改变。
J Neuropathol Exp Neurol. 2003 Feb;62(2):137-45. doi: 10.1093/jnen/62.2.137.
4
Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex.成年皮质中经验依赖性突触可塑性的长期体内成像
Nature. 2002;420(6917):788-94. doi: 10.1038/nature01273.
5
Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.非Fc介导的机制参与了免疫疗法在体内清除β-淀粉样蛋白的过程。
J Neurosci. 2002 Sep 15;22(18):7873-8. doi: 10.1523/JNEUROSCI.22-18-07873.2002.
6
Geometry and structural plasticity of synaptic connectivity.突触连接的几何学与结构可塑性
Neuron. 2002 Apr 11;34(2):275-88. doi: 10.1016/s0896-6273(02)00652-9.
7
Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption.阿尔茨海默病转基因模型中斑块诱导的神经突几何形状异常:对神经系统破坏的影响。
J Neuropathol Exp Neurol. 2001 Aug;60(8):753-8. doi: 10.1093/jnen/60.8.753.
8
Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
J Neuropathol Exp Neurol. 2001 Apr;60(4):357-68. doi: 10.1093/jnen/60.4.357.
9
Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.对活体小鼠大脑中β淀粉样蛋白沉积物进行成像,有助于直接观察免疫疗法对斑块的清除情况。
Nat Med. 2001 Mar;7(3):369-72. doi: 10.1038/85525.
10
A plasticity-based theory of the pathogenesis of Alzheimer's disease.
Ann N Y Acad Sci. 2000;924:42-52. doi: 10.1111/j.1749-6632.2000.tb05559.x.